Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you

ETFMG Treatments, Testing and Advancements ETF

etf
GERM
Dividend policy
None
Price as of:
$32.8 +0.33 +0%
primary theme
Health Care Sector Equity
GERM (ETF)

ETFMG Treatments, Testing and Advancements ETF

Dividend policy
None
Price as of:
$32.8 +0.33 +0%
primary theme
Health Care Sector Equity
GERM (ETF)
ETFMG Treatments, Testing and Advancements ETF
Dividend policy
None
Price as of:
$32.8 +0.33 +0%
primary theme
Health Care Sector Equity

GERM - Snapshot

Vitals

  • YTD Return N/A
  • 3 Yr Annualized Return N/A
  • 5 Yr Annualized Return N/A
  • Net Assets $60.3 M
  • Holdings in Top 10 56.8%

52 WEEK LOW AND HIGH

$32.47
$24.63
$33.91

Expenses

OPERATING RELATED FEES

  • Expense Ratio N/A

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover N/A

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA N/A

Fund Classification

  • Primary Theme Health Care Sector Equity
  • Fund Type Exchange Traded Fund
  • Investment Style Health

Compare GERM to Popular Health Care Sector Equity Funds

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$109.21

+0.57%

$14.12 B

1.17%

$1.27

blocked
blocked
blocked

13.82%

-

Compare GERM to Popular Health Care Sector Equity ETFs

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$111.49

+0.75%

$24.57 B

1.49%

$1.65

blocked
blocked
blocked

9.32%

-

$218.28

+0.49%

$14.12 B

1.17%

$2.55

blocked
blocked
blocked

13.84%

-

$144.99

-0.23%

$9.78 B

0.21%

$0.30

blocked
blocked
blocked

21.52%

-

$315.37

+0.50%

$8.75 B

0.27%

$0.84

blocked
blocked
blocked

19.03%

-

$132.82

-0.09%

$6.82 B

0.08%

$0.11

blocked
blocked
blocked

40.60%

-

GERM - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    ETFMG Treatments, Testing and Advancements ETF
  • Fund Family Name
    ETFMG
  • Inception Date
    Jun 17, 2020
  • Shares Outstanding
    1799999
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Donal Bishnoi

Fund Description

The fund invests at least 80% of its total assets in the component securities of the index. The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.


GERM - Performance

Return Ranking - Trailing

Period GERM Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -3.6% 157.0% N/A
1 Yr N/A 1.8% 148.1% N/A
3 Yr N/A* 2.7% 51.8% N/A
5 Yr N/A* -0.5% 34.2% N/A
10 Yr N/A* 9.6% 21.4% N/A

* Annualized

Return Ranking - Calendar

Period GERM Return Category Return Low Category Return High Rank in Category (%)
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A
2015 N/A -62.4% 27.9% N/A

Total Return Ranking - Trailing

Period GERM Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -3.6% 147.2% N/A
1 Yr N/A -3.5% 148.1% N/A
3 Yr N/A* 1.8% 51.8% N/A
5 Yr N/A* -0.5% 34.2% N/A
10 Yr N/A* 9.5% 21.4% N/A

* Annualized

Total Return Ranking - Calendar

Period GERM Return Category Return Low Category Return High Rank in Category (%)
2019 N/A 3.8% 63.8% N/A
2018 N/A -25.3% 22.2% N/A
2017 N/A -10.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A
2015 N/A -16.6% 27.9% N/A

GERM - Holdings

Concentration Analysis

GERM Category Low Category High GERM % Rank
Net Assets 60.3 M 4.64 M 46 B 75.58%
Number of Holdings 65 24 426 73.26%
Net Assets in Top 10 34.9 M 1.01 M 19.6 B 73.26%
Weighting of Top 10 56.79% 15.4% 77.0% 7.56%

Top 10 Holdings

  1. Moderna Inc 11.69%
  2. BioNTech SE ADR 8.94%
  3. Emergent BioSolutions Inc 5.74%
  4. CU 5.64%
  5. Quest Diagnostics Inc 4.91%
  6. Laboratory Corp of America Holdings 4.85%
  7. Bio-Rad Laboratories Inc 4.69%
  8. Zai Lab Ltd ADR Repr 1 Shs 4.36%
  9. Novavax Inc 4.36%
  10. Vir Biotechnology Inc 3.97%

Asset Allocation

Weighting Return Low Return High GERM % Rank
Stocks
97.57% 76.86% 100.05% 60.47%
Bonds
1.78% 0.00% 16.11% 1.74%
Cash
0.59% -0.28% 12.53% 61.63%
Convertible Bonds
0.05% 0.00% 0.05% 0.58%
Preferred Stocks
0.00% 0.00% 4.75% 90.70%
Other
0.00% -1.51% 10.43% 85.47%

Stock Sector Breakdown

Weighting Return Low Return High GERM % Rank
Healthcare
100.00% 61.64% 100.00% 29.65%
Utilities
0.00% 0.00% 0.00% 88.37%
Technology
0.00% 0.00% 15.86% 90.70%
Real Estate
0.00% 0.00% 6.03% 90.12%
Industrials
0.00% 0.00% 5.94% 90.70%
Financial Services
0.00% 0.00% 3.21% 91.28%
Energy
0.00% 0.00% 0.00% 88.37%
Communication Services
0.00% 0.00% 4.69% 88.37%
Consumer Defense
0.00% 0.00% 33.59% 89.53%
Consumer Cyclical
0.00% 0.00% 1.21% 88.95%
Basic Materials
0.00% 0.00% 3.14% 91.28%

Stock Geographic Breakdown

Weighting Return Low Return High GERM % Rank
US
74.14% 56.70% 99.99% 78.49%
Non US
23.43% 0.00% 43.24% 18.60%

Bond Sector Breakdown

Weighting Return Low Return High GERM % Rank
Corporate
73.77% 0.00% 100.00% 4.91%
Cash & Equivalents
24.41% 0.00% 100.00% 95.09%
Securitized
1.64% 0.00% 1.64% 0.61%
Municipal
0.19% 0.00% 0.19% 0.61%
Derivative
0.00% 0.00% 36.19% 88.96%
Government
0.00% 0.00% 52.48% 88.34%

Bond Geographic Breakdown

Weighting Return Low Return High GERM % Rank
US
1.37% 0.00% 16.11% 1.74%
Non US
0.41% 0.00% 0.41% 0.58%

GERM - Expenses

Operational Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio N/A 0.08% 25.14% N/A
Management Fee 0.68% 0.00% 1.25% 56.98%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.70% 252.00% N/A

GERM - Distributions

Dividend Yield Analysis

GERM Category Low Category High GERM % Rank
Dividend Yield 0.00% 0.00% 3.15% 93.60%

Dividend Distribution Analysis

GERM Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

GERM Category Low Category High GERM % Rank
Net Income Ratio N/A -2.53% 2.53% N/A

Capital Gain Distribution Analysis

GERM Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Dividend Payout History

View More +

GERM - Fund Manager Analysis

Managers

Donal Bishnoi


Start Date

Tenure

Tenure Rank

Jun 17, 2020

0.45

0.5%

Donal A. Bishnoi, CFA, has more than 16 years of experience in portfolio management and risk management. Prior to joining ETF Managers Group, LLC, Mr. Bishnoi held a senior portfolio management position with Oppenheimer Funds from 2018 to 2019 where he was responsible for managing approximately $5 billion in assets across 20 passive strategies. In his previous role at the Oppenheimer Funds Inc. he was a risk manager for the equity mutual funds and exchange traded funds. Prior to joining Oppenheimer Funds in 2010, Mr. Bishnoi managed a long/short systematic equity strategy at Moore Capital from 2007 to 2009. Mr. Bishnoi received a B.S. in Finance from the Boston University. He is a Chartered Financial Analyst charter holder from the CFA Institute.

Devin Ryder


Start Date

Tenure

Tenure Rank

Jun 17, 2020

0.45

0.5%

Devin Ryder began her career with ETF Managers Group LLC during the summer of 2017 and re‑joined ETF Managers Group LLC on a permanent basis in 2018 to be a part of the portfolio management team. Prior to joining ETF Managers Group LLC, Ms. Ryder was pursuing studies in the quantitative aspects of risk management and finance, for which she received a B.S. in Mathematics of Finance and Risk Management from the University of Michigan in 2017.

Frank Vallario


Start Date

Tenure

Tenure Rank

Jun 17, 2020

0.45

0.5%

Frank Vallario serves in the role of Chief Investment Officer for the ETF Managers Group, LLC. Mr. Vallario is responsible for the portfolio construction, trading, risk management and portfolio analysis processes associated with ETF strategies. Prior to his current role, Mr. Vallario has had a variety of senior roles over his 25-year career in financial services. He joined Oppenheimer Funds in 2017 where he was Head of Equity Portfolio Management for Smart Beta ETFs. Prior to that he was Senior Portfolio Manager at Columbia Threadneedle from September 2015 to June 2017 where he was responsible for the day to day management of the firm’s ETF business, which was acquired from his previous firm, Emerging Global Advisors (EGA). From September 2010 to September 2015, he was relationship manager at MSCI responsible for providing investment solutions to complex problems using MSCI Barra’s fundamental models and portfolio construction tools. Previously, he was a partner in a start-up asset management firm where he served as the director of portfolio management. Mr. Vallario began his career at UBS Global Asset Management where he spent over a decade in various quantitative portfolio management equity roles including equity market neutral, tactical asset allocation, structured active equities, enhanced index, passive management and factor research. Mr. Vallario serves on the Investment Committee for the Girl Scouts of Connecticut and is a University Affiliate at the University of Utah - David Eccles School of Business. He received a B.S. in Finance from Lehigh University and a M.B.A. with a concentration in Finance from Rutgers University.

Samuel Masucci


Start Date

Tenure

Tenure Rank

Jun 17, 2020

0.45

0.5%

Samuel Masucci, III has more than 25 years’ experience in investment banking, structured product development, sales and trading. In the last 5 years, he founded ETF Managers Group (ETFMG) hich has led to the launch of 15 funds and $3 billion in assets. . Prior to ETFMG, Mr. Samuel Masucci, III has held senior positions at Bear Stearns, UBS, SBC Warburg, and Merrill Lynch and has experience in creating, building and managing businesses for the issuance, sales and trading of: ETFs, index products, commodity products, hedge funds, ABS, and OTC structured products in the U.S. and Europe.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.17 23.22 7.36 20.6

Continue to site >
Trending ETFs